Inclusion Complex of Fenbufen with β-Cyclodextrin

Biopolymers

Volumn 73, Issue 4, 2004, Pages 451-456

  Bratu, I ^a   Gavira Vallejo, J M ^b   Hernanz, A ^b   Bogdan, M ^a   Bora, Gh ^c  

^a NATIONAL INSTITUTE FOR RESEARCH AND DEVELOPMENT OF ISOTOPIC AND MOLECULAR TECHNOLOGIES   (Romania)

^b UNIVERSIDAD NACIONAL DE EDUCACIÓN A DISTANCIA   (Spain)

^c NONE   (Romania)

Author keywords

1H NMR; Antiinflammatory drugs; Fenbufen; Inclusion complexes; Molecular modeling; Stability constant; Stoichiometry; cyclodextrin

Indexed keywords

GEOMETRY; MOLECULES; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; SOLUTIONS; STABILITY; STOICHIOMETRY;

INCLUSION COMPLEXES; MOLECULAR MECHANICS;

COMPLEXATION;

ANTIINFLAMMATORY AGENT; BETA CYCLODEXTRIN; FENBUFEN;

AQUEOUS SOLUTION; ARTICLE; CALCULATION; COMPLEX FORMATION; DRUG PROTEIN BINDING; DRUG STABILITY; GASTROINTESTINAL TOXICITY; HUMAN; MOLECULAR MECHANICS; MOLECULAR MODEL; PROTEIN STABILITY; PROTON NUCLEAR MAGNETIC RESONANCE; RASH; STOICHIOMETRY;

BETA-CYCLODEXTRINS; CYCLODEXTRINS; DRUG COMBINATIONS; DRUG STABILITY; HYPOGLYCEMIC AGENTS; MAGNETIC RESONANCE SPECTROSCOPY; MODELS, MOLECULAR; MOLECULAR STRUCTURE; PHENYLBUTYRATES; SOLUTIONS; THERMODYNAMICS; WATER;

EID: 1542724788     PISSN: 00063525     EISSN: None     Source Type: Journal    
DOI: 10.1002/bip.10555     Document Type: Article

References (22)

1. Navaratnam, S.; Jones, S. A. J Photochem Photobiol A Chem 2000, 132, 175-180.
2. Sortino, S.; Giuffrida, S.; Fazio, S.; Monti, S. New J Chem 2001, 25, 707-713.
3. Krasowska, H.; Krówczynski, L. Pharmazie 1996, 51, 353-358.
4. Krasowska, H.; Czechowska, D.; Bura, I. Acta Polym Pharm 1997, 54, 25-30.
5. Sortino, S.; Martinez, L. J.; Marconi, G. New J Chem 2001, 25, 975-980.
6. Monti, S.; Sortino, S. Chem Soc Rev 2002, 31, 287-300.
7. Kurozumi, M.; Nambu, N.; Nagai, T. Chem Pharm Bull 1975, 23, 3062-3068.
8. Meier, M. M.; Luiz, M. T. B.; Farmer, P. J.; Szpoganicz, B. J Incl Phenom Macromol 2001, 40, 291-295.
9. Zorzona, A.; Martin, C.; Sanchez, M.; Velaz, I.; Piquer, A. Int J Pharm 1998, 169, 239-244.
10. Miyaji, T.; Inoue, Y.; Acartuk, F.; Imai, T.; Otagiri, M.; Uekama, K. Acta Pharm Nord 1992, 4, 17-22.
11. Job, P. Ann Chim 1928, 9, 113-203.
12. Bogdan, M.; Farcas, S. I.; Bojita, M. Studia Univ Babes-Bolyai Ser Phys 2000, Special Issue, 115-120.
13. Saenger, W. Angew Chem Int Ed 1980, 92, 343-361.
14. Li, S.; Purdy, W. C. Chem Rev 1992, 92, 1457-1470.
15. Pastor, O.; Junquera, E.; Aicart, A. Langmuir 1998, 14, 2950-2957.
16. Tran, C. D.; De Paoli Lacerda, S. H. Anal Chem 2002, 74, 5337-5341.
17. Hypercube, Inc. HyperChem™, Release 4; Hypercube, Inc.: Waterloo, Ontario, Canada, 1994.
18. Hypercube, Inc. Computational Chemistry; Hypercube, Inc.: Waterloo, Ontario, Canada, 1994.
19. OriginLab Corporation. Origin® 7.0; OriginLab Corporation: Northhampton, MA, 2002.
20. Zubiaur, M.; Jaime, C. J Org Chem 2000, 65, 8139-8145.
21. Liu, L.; Guo, Q.-X. J Incl Phenom Macromol 2002, 42, 1-14.
22. Gavira, J. M.; Hernanz, A.; Bratu, I. Vibr Spectrosc, 2003, 32, 137-146.